In ₹ Crore except Per Share Latest Annual	HALEOSLABS FY26	ALBERTDAVD FY26	VALIANTLAB FY26	MEDICO FY26	Peer Average
Valuation — at last close
P/E	25.33×	—	—	◆ 12.16×	12.16× +108%
P/B	2.05×	◆ 1.13×	2.20×	2.11×	1.81× +13%
EV/EBITDA	12.56×	38.64×	108.79×	◆ 10.26×	52.56× -76%
Market Cap	₹439 Cr	₹441 Cr	₹683 Cr	₹160 Cr	₹428 Cr +3%
Growth
Revenue CAGR 3Y	1.89%	-0.78%	—	◆ 13.69%	6.46% -71%
Revenue CAGR 5Y	4.68%	◆ 6.16%	—	—	6.16% -24%
Net Income CAGR 3Y	16.09%	—	—	◆ 21.89%	21.89% -26%
Revenue YoY (latest Q)	-11.59%	43.60%	◆ 146.22%	81.43%	90.42% -113%
Net Income YoY (latest Q)	-58.00%	303.12%	◆ 1058.93%	38.49%	466.85% -112%
Profitability
EBITDA Margin	◆ 13.38%	1.64%	2.69%	8.25%	4.19% +219%
Net Income Margin	5.33%	-0.45%	-1.38%	◆ 6.35%	1.51% +254%
Return on Common Equity	8.44%	-0.38%	-1.20%	◆ 19.04%	5.82% +45%
Return on Capital Employed	10.70%	-1.06%	0.10%	◆ 20.13%	6.39% +67%
Return on Assets	4.22%	-0.29%	-0.76%	◆ 9.61%	2.85% +48%
Credit & Quality
Total Debt/Equity	0.47×	◆ 0.07×	0.14×	0.25×	0.15× +207%
Interest Coverage	4.53×	-1.63×	0.18×	◆ 7.71×	2.09× +117%
Scale — latest FY
Revenue / Total Income	₹334 Cr	₹334 Cr	₹237 Cr	₹206 Cr	₹259 Cr +29%
Net Income	₹17.8 Cr	−₹1.5 Cr	−₹3.3 Cr	₹13.1 Cr	₹2.8 Cr +539%
Total Assets	₹454 Cr	₹519 Cr	₹464 Cr	₹153 Cr	₹379 Cr +20%
EPS	₹57.26	₹-2.62	₹-0.51	₹1.58	₹-0.52 +11183%
Book Value per Share	₹706.34	₹686.04	₹57.24	₹9.09	₹250.79 +182%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.